Oramed Provides Update on Oravax: Oral Vaccine Maker Gets IRB Approval for Clinical Trial July 21, 2021 Press Releases
Oramed Issues Letter to Shareholders with Updates on Oral Insulin and COVID-19 Vaccine May 25, 2021 Press Releases
Oramed Pharmaceuticals and Oravax Medical to be Featured in Alliance Global Partners’ Grand Rounds: A Webinar in Biotech and Specialty Pharma April 21, 2021 Press Releases
Oramed Initiates Second Phase 3 Oral Insulin Study Under the FDA’s Approved Dual Concurrent Protocol March 23, 2021 Press Releases
Oramed Forms a Joint Venture, Oravax Medical Inc., for the Development of Novel Oral COVID-19 Vaccines March 19, 2021 Press Releases
Oramed Reaches 25% Randomization in World’s First Phase 3 Oral Insulin Study Conducted Under FDA Approved Protocol March 16, 2021 Press Releases
Oramed to Present at H.C. Wainwright Global Life Sciences Conference 2021 March 4, 2021 Press Releases
